Testing effectiveness (Phase 2)Looking for participantsNCT05919108
What this trial is testing
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
Who this might be right for
Anatomic Stage I Breast CancerAnatomic Stage II Breast CancerAnatomic Stage III Breast Cancer+1 more
Vanderbilt-Ingram Cancer Center 30